【Public Consultation】Submission of Comments on the “Draft Guidelines for Ensuring the Appropriateness of Research & Development and Utilization of AI-Related Technologies”

【Public Consultation】Submission of Comments on the “Draft Pharmaceuticals designated by the Minister of MHLW based pursuant to Article 36-11, Paragraph 1 of the PMD Act and the “Draft Quantities determined by Minister of MHLW pursuant to Article 159-18-6, Paragraph 1 of the Ordinance for Enforcement of the PMD Act by the MHLW

Comment: Submitted Comments at the 11th Digital Society Initiative Conference, Digital Agency

Event Report: JX Live! 2025

【Public Consultation】Submission of Comments on the Ministry of Health, Labour and Welfare’s “Draft Ministerial Ordinance for the Development of Related Ministerial Ordinances in conjunction with the Enforcement of Part of the Act for Partial Revision of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, etc.”

【Public Consultation】We submitted our views on the Cabinet Office’s draft “Basic Approach for the 6th Basic Plan for Gender Equality.”

Released “Regulatory Reform Proposal 2025”

【Presentation】Delivered Comments at the Ministry of Education, Culture, Sports, Science and Technology (MEXT) “Working Group on New Approaches to Evaluation for Improving the Quality of Education and Learning (5th Meeting)

【Public Consultation】Submission of Comments on the “Mobile Software Competition Act Guidelines (Draft)”

A Statement from JANE Representative Director Mickey Mikitani on the Enactment of the Bill for Partial Amendment to the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices